Literature DB >> 9731019

Pneumonia in acute respiratory distress syndrome. A prospective evaluation of bilateral bronchoscopic sampling.

G U Meduri1, R C Reddy, T Stanley, F El-Zeky.   

Abstract

We evaluated the diagnostic yield of bilateral bronchoalveolar lavage (BAL) in patients with acute respiratory distress syndrome (ARDS) with suspected ventilator-associated pneumonia (VAP) and compared BAL results from contralateral sites. Ninety-four ARDS patients with suspected VAP underwent 172 bronchoscopies (344 BALs). BAL was processed for quantitative cultures, total cell count and subjected to microscopic analysis for cell differential, presence of intracellular organisms (ICO), and Gram stain. The diagnostic threshold for VAP was a growth of >= 10(4) cfu/ml in BAL culture. Most episodes (68%) had bilateral insignificant bacterial growth. Forty (43%) patients had one or more episodes of VAP. Thirty-three of the 55 (60%) positive bronchoscopies had significant growth in only one side, 18 were right BAL, and 15 were left BAL. Episodes with bilateral significant growth were more likely to be polymicrobial, to have a bacterial growth >= 10(5) cfu/ml in the BAL, and to possess a higher percentage of neutrophils and ICO. Among 65 microorganisms recovered in significant concentration, Pseudomonas aeruginosa occurred in 43% and S. aureus in 15%. Overall, Gram stain had a sensitivity of 54% and a specificity of 87%; and Giemsa stain (> 2% ICO) had a sensitivity of 46% and a specificity of 93%. Antibiotic treatment was modified by the results of BAL cultures in 50 (91%) episodes of pneumonia. In patients with ARDS and suspected VAP, bilateral BAL quantitative bacterial cultures had significant growth on one side only in 19% and in both sides in 13%.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9731019     DOI: 10.1164/ajrccm.158.3.9706112

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  21 in total

Review 1.  Acute respiratory distress syndrome and nosocomial pneumonia.

Authors:  T T Bauer; A Torres
Journal:  Thorax       Date:  1999-11       Impact factor: 9.139

2.  Ventilator-associated pneumonia: diagnosis, treatment, and prevention.

Authors:  Steven M Koenig; Jonathon D Truwit
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

3.  The proinflammatory role of HECTD2 in innate immunity and experimental lung injury.

Authors:  Tiffany A Coon; Alison C McKelvey; Travis Lear; Shristi Rajbhandari; Sarah R Dunn; William Connelly; Joe Y Zhao; SeungHye Han; Yuan Liu; Nathaniel M Weathington; Bryan J McVerry; Yingze Zhang; Bill B Chen
Journal:  Sci Transl Med       Date:  2015-07-08       Impact factor: 17.956

4.  Efficacy of bilateral bronchoalveolar lavage for diagnosis of ventilator-associated pneumonia.

Authors:  Colleen R Zaccard; Ronald F Schell; Carol A Spiegel
Journal:  J Clin Microbiol       Date:  2009-07-15       Impact factor: 5.948

5.  Alleviation of gram-negative bacterial lung inflammation by targeting HECTD2.

Authors:  Rick Kapur; John W Semple
Journal:  Ann Transl Med       Date:  2016-12

6.  Mortality factor 4 like 1 protein mediates epithelial cell death in a mouse model of pneumonia.

Authors:  Chunbin Zou; Jin Li; Sheng Xiong; Yan Chen; Qin Wu; Xiuying Li; Nathaniel M Weathington; SeungHye Han; Courtney Snavely; Bill B Chen; Rama K Mallampalli
Journal:  Sci Transl Med       Date:  2015-10-28       Impact factor: 17.956

Review 7.  Antibacterial treatment of invasive mechanical ventilation-associated pneumonia.

Authors:  F Barcenilla; E Gascó; J Rello; L Alvarez-Rocha
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

Review 8.  Approach to the patient with the acute respiratory distress syndrome.

Authors:  David R Janz; Lorraine B Ware
Journal:  Clin Chest Med       Date:  2014-09-26       Impact factor: 2.878

9.  Blockade of equilibrative nucleoside transporter 1/2 protects against Pseudomonas aeruginosa-induced acute lung injury and NLRP3 inflammasome activation.

Authors:  Eboni D Chambers; Alexis White; Alexander Vang; Zhengke Wang; Alfred Ayala; Tingting Weng; Michael Blackburn; Gaurav Choudhary; Sharon Rounds; Qing Lu
Journal:  FASEB J       Date:  2019-12-02       Impact factor: 5.191

10.  Chitinase 3-Like 1 (Chil1) Regulates Survival and Macrophage-Mediated Interleukin-1β and Tumor Necrosis Factor Alpha during Pseudomonas aeruginosa Pneumonia.

Authors:  Chad R Marion; Jianmiao Wang; Lokesh Sharma; Ashley Losier; Wei Lui; Nathaniel Andrews; Jack A Elias; Barbara I Kazmierczak; Craig R Roy; Charles S Dela Cruz
Journal:  Infect Immun       Date:  2016-06-23       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.